Prerequisites for Optimized Performance of the Eisai 1088W Automated Inspection System

References

1. 1.↵
   1. Leversee R. L.,
   2. Shabushnig J. G.

   A Survey of Industry Practice for the Visual Inspection of Injectable Products (PDA Preliminary Report). Paper presented at the PDA Visual Inspection Forum, Berlin, Germany, 2008.
2. 2.↵
   1. Knapp J. Z.,
   2. Kushner H. K.

   Generalized methodology for evaluation of parenteral inspection procedures. J. Parenter. Drug Assoc. 1980, 34 (1), 14–61.

   OpenUrlPubMed
3. 3.↵
   1. Knapp J. Z.,
   2. Zeiss J. G.,
   3. Thompson B. J.,
   4. Crane J. S.,
   5. Dunn P.

   Inventory and measurement of particulates in sealed sterile containers. J. Parenter. Sci. Technol. 1983, 37 (5), 170–179.

   OpenUrlPubMed
4. 4.↵
   1. Knapp J. Z.

   The scientific basis for visible particle detection. PDA J. Pharm. Sci. Technol. 1999, 53 (6), 291–302.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Melchore J. A.

   Establishing a Statistically Sound Manual Inspection Baseline. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2009.
6. 6.↵
   1. Cherris R. T.

   Visible Particulate Inspection. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2005.
7. 7.↵
   1. Knapp J. Z.

   Overview of Accurate NIST Traceably Sized Dimensions of Visible Particulate Contamination Data in Sealed Containers of Injectable Products: An Essential Validation and Product Acceptance Tool. Paper presented at the PDA Visible Inspection Forum, Bethesda, MD, 2007.
8. 8.↵
   1. Melchore J. A.

   Lessons learned regarding particulate inspection. PDA Metro Chapter, 2007.
9. 9.↵
   1. Shabushnig J. G.,
   2. Melchore J. A.,
   3. Geiger M.,
   4. Chrai S.,
   5. Gerger M. E.

   A Proposed Working Standard for the Validation of Particulate Inspection in Sterile Solutions. Podium presentation at the PDA Annual Meeting, Philadelphia, PA, 1994.
10. 10.↵
    1. Knapp J.

    The Bridge Between Visible Particle Data and the Accuracy and Repeatability Requirements of PAT: One Safe Step at a Time. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2005.
11. 11.↵
    1. Borchert S. J.,
    2. Maxwell R. J.,
    3. Davidson R. L.,
    4. Aldrich D. S.

    Standard particulate sets for visual inspection systems: their preparation, evaluation and applications. J. Parenter. Sci. Technol. 1986, 40 (6) 265–276.

    OpenUrlPubMed
12. 12.↵
    1. Borchert S. J.,
    2. Abe A.,
    3. Aldrich S.,
    4. Fox L. E.,
    5. Freeman J. E.,
    6. White R. W.

    Particulate matter in parenteral products: a review. J. Parenter. Sci. Technol. 1986, 40 (5), 212–241.

    OpenUrlPubMed
13. 13.↵
    1. Budd G.

    NIST Traceable Automated contaminating particle measurements using the NSIT ParticleScope™System. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2009.
14. 14.↵
    1. Rathore N.,
    2. Chen C.,
    3. Gonzalez O.,
    4. Wenchang J.

    Challenges and strategies for implementing automated visual inspection for biopharmaceuticals. J. PharmTech.com. Injectable Drug Delivery Supplement. 2009, 33 (S25).
15. 15.↵
    1. Singh S. K.,
    2. Rathore N.,
    3. McAuley A.,
    4. Rathore A. S.

    Best practices for formulation and manufacturing of biotech drug products. Biopharm Int. 2009, 22 (6), 32–48.

    OpenUrl
16. 16.↵
    1. Knapp J. Z.,
    2. Abramson L. R.

    Automated particulate inspection systems: strategies and implications. J. Parenter. Sci. Technol. 1989, 44 (2), 74–107.

    OpenUrl
17. 17.↵
    1. Knapp J. Z.

    “Absolute” sterility and “absolute” freedom from particulate inspection. PDA J. Pharm. Sci. Technol. 1998, 52 (4), 173–181.

    OpenUrlAbstract/FREE Full Text